
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Olive
Therapeutic Area : Gastroenterology
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Oral Mucositis and Quality of Life With a Mucosa Topical Composition in Head & Neck Cancer Patients.
Details : Olive Oil is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Stomatitis.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
December 02, 2022
Lead Product(s) : Olive
Therapeutic Area : Gastroenterology
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Olive
Therapeutic Area : Undisclosed
Study Phase : Phase II/ Phase III
Sponsor : Universidad de Granada
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Olive is a drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
July 19, 2022
Lead Product(s) : Olive
Therapeutic Area : Undisclosed
Highest Development Status : Phase II/ Phase III
Sponsor : Universidad de Granada
Deal Size : Inapplicable
Deal Type : Inapplicable
